INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers (INDIGO-2)

February 7, 2020 updated by: Arizona State University
Previous studies have indicated increased vasopressin due to hypertonic saline infusion impairs glucose regulation. The current study will examine the effect of low water intake on glucose regulation. No currently published study has investigated the acute effect of low water intake on glucose regulation using continuous glucose monitoring over the course of a full day. The aim of the study is to observe the effect of low water intake on glucose regulation in low drinkers. The study will study the glycemic responses to standardized meals in adults during an 11-hour period in two conditions: a) high water intake and b) low water intake. It is hypothesized that the area under the glucose curve will be greater in the low water intake trial as compared to the high water intake trial

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85004
        • Arizona Biomedical Collaborative

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy sedentary participants
  • aged 30-55 years
  • body mass 27.5-35.0 kg·m2
  • low water intake less than 1.5 L∙day-1 (male) or 1.0 L∙day-1 (female)
  • 24 h urine osmolality greater than 800 mmol/kg

Exclusion Criteria:

  • diabetes HbA1c >6.5%
  • impaired liver or kidney function
  • cardiovascular disease
  • weight change of more than 3 kg in the past month
  • pregnancy
  • previous surgery on digestive tract
  • exercise >4 h/week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: High Water intake
High water intake of 3.0 L/day in males and 2.0 L/day in females
Increased water intake during the 11 h protocol
ACTIVE_COMPARATOR: Low Water Intake
Low water intake of 0.5 L/day in males and 0.4 L/day
Increased water intake during the 11 h protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Area under the curve of Glucose at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Area under the curve of Glucose at Dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Area under the curve of Glucose for the entire experiment
Time Frame: 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
Area under the curve of Copeptin for the entire experiment
Time Frame: 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
Area under the curve of Glucagon at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Area under the curve of Glucagon at dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Urinary glucose excretion
Time Frame: Entire 11-hour protocol 7:00 am - 6:00 pm
Entire 11-hour protocol 7:00 am - 6:00 pm
Area Under the Curve for Plasma osmolality
Time Frame: the entire 11-hour protocol 7:00 am - 6:00 pm
the entire 11-hour protocol 7:00 am - 6:00 pm

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area under the curve of Insulin at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Area under the curve of Insulin at dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Area under the curve of Glucagon like peptide 1 at dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Area under the curve of Glucagon like peptide 1at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Area under the curve of plasma cortisol
Time Frame: the entire 11-hour protocol 7:00 am - 6:00 pm
the entire 11-hour protocol 7:00 am - 6:00 pm
Area under the curve for Thirst rating
Time Frame: the entire 11-hour protocol 7:00 am - 6:00 pm
Thirst assessed by Visual analog scale
the entire 11-hour protocol 7:00 am - 6:00 pm
Mood assessment with a questionnaire
Time Frame: single measurement at baseline before the beginning of breakfast at 7:00 am and 1-hour before dinner meal at 3:00 pm
Assessed by Profile of mood state questionnaire
single measurement at baseline before the beginning of breakfast at 7:00 am and 1-hour before dinner meal at 3:00 pm

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 18, 2019

Primary Completion (ACTUAL)

December 19, 2019

Study Completion (ACTUAL)

December 19, 2019

Study Registration Dates

First Submitted

August 27, 2019

First Submitted That Met QC Criteria

August 30, 2019

First Posted (ACTUAL)

September 4, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 11, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Water Intake

Subscribe